Article Listing - Ipsen leaps on strong first-half results; expands links with Inspiration Biopharma and names new CFO

MORE ICI PUERTO RICO INVESTMENT

16 March 1992

Imperial Chemical Industries' subsidiary IPR Pharmaceutical Inc is to make a new investment of $10 million in the development of...

CANLAC LACTULOSE PLANT FOR CANADA

16 March 1992

Canlac Corp of Canada has ann-ounced that it is to build a new pharmaceutical production facility in Victoriaville, Quebec, as...

US FDA BIOTECH REVIEW MOVES

16 March 1992

The approval of biotechnology-derived products is to be speeded up, and the US Food and Drug Administration will hire 50...

US BIOTECH, C-R MARKET FORECASTS

16 March 1992

The US biotechnology industry will grow by 15.9% a year from a value of close to $8.7 billion in 1990...

DRUG LISTING IN ISRAEL'S KORATH

16 March 1992

In 1991, the Committee of the Korath (Israel's compendium for drug therapy) dealt with 25 applications for inclusion, of which...

CUBA BOOSTS HEALTH CARE IMPORTS

16 March 1992

The ending of trade relations with the previously-Communist eastern European member states of COMECON has resulted in a serious reduction...

ACF 1991 RESULTS

16 March 1992

- Dutch pharmaceutical wholesaler ACF Holding NV reports that 1991 net profit was boosted 68% to 23.8 million guilders ($12.7...

SHENZHEN PHARMA OUTPUT IN 1991

16 March 1992

- China's Xinhua news agency reports that the Shenzhen South China Pharmaceutical Factory has recorded a total output value of...

SALE OF FERMENTA'S INDEPENDENT

16 March 1992

- A consortium of Swedish banks is to buy Fermenta's financial subsidiary Independent for one billion Swedish kroner ($169 million),...

GANZYME'S CEREDASE 1991 SALES

16 March 1992

- Sales of Genzyme's Gaucher's disease treatment Ceredase (alglucerase) in 1991 were $39.6 million, slightly above earlier projections of $38...

Showing 94841-94850 of 95569 articles

Go to beginningPreviousNextGo to end